Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.31
Delayed Data
As of May 21
 0.00 / 0.00%
Today’s Change
0.97
Today|||52-Week Range
2.02
-30.69%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.31
Today’s open1.30
Day’s range-- - --
Volume339,978
Average volume (3 months)500,934
Market cap$197.5M
Dividend yield--
Data as of 05/21/2015

Growth & Valuation

Earnings growth (last year)+31.43%
Earnings growth (this year)+30.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+454.99%
P/E ratioNM
Price/Sales44.80
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ALIMAlimera Sciences Inc-0.04-0.89%
HSKAHeska Corp+0.77+2.64%
RPRXRepros Therapeutics ...-0.05-0.65%
GALEGalena Biopharma Inc+0.03+2.31%
Data as of 05/21/2015

Financials

Last reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$6.3M
Annual profit (last year)-$35.7M
Net profit margin-569.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ricardo J. Gonzalez
CFO, Secretary, Treasurer &
Executive VP
Brent L. Larson
Corporate headquarters
Dublin, Ohio

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers